This company listing is no longer active
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Idogen Gestion
Gestion contrôle des critères 1/4
Idogen's CEO is Christina Herder, appointed in Sep 2022, they has a tenure of less than a year. Their total yearly compensation is SEK454.00K , comprised of 66.1% salary and 33.9% bonuses, including company stock and options. They directly owns 0.06% of the company’s shares, worth SEK7.56K. The average tenure of the management team and the board of directors is 1.5 years and 2.7 years respectively.
Informations clés
Christina Herder
Directeur général
SEK 454.0k
Rémunération totale
| Pourcentage du salaire du PDG | 66.1% |
| Durée du mandat du directeur général | less than a year |
| Propriété du PDG | 0.06% |
| Durée moyenne d'occupation des postes de direction | 1.5yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 2.7yrs |
Mises à jour récentes de la gestion
Recent updates
Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Mar 31 2023 | n/a | n/a | -SEK 44m |
| Dec 31 2022 | SEK 454k | SEK 300k | -SEK 48m |
| Sep 30 2022 | n/a | n/a | -SEK 50m |
| Jun 30 2022 | n/a | n/a | -SEK 41m |
| Mar 31 2022 | n/a | n/a | -SEK 39m |
| Dec 31 2021 | SEK 150k | n/a | -SEK 39m |
| Sep 30 2021 | n/a | n/a | -SEK 33m |
| Jun 30 2021 | n/a | n/a | -SEK 33m |
| Mar 31 2021 | n/a | n/a | -SEK 31m |
| Dec 31 2020 | SEK 150k | n/a | -SEK 27m |
Rémunération vs marché: Christina's total compensation ($USD42.19K) is below average for companies of similar size in the Swedish market ($USD231.64K).
Rémunération et revenus: Christina's compensation has increased whilst the company is unprofitable.
PDG
Christina Herder (62 yo)
less than a year
Titularisation
SEK 454,000
Compensation
Dr. Christina Herder, Ph D., served as Independent Director for Ziccum AB (publ) since April 28, 2022 until May 2023. She is Director at Beactica AB since 2021.She is a Director at Elicera Therapeutics AB...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Acting CEO & Director | less than a year | SEK 454.00k | 0.060% SEK 7.6k | |
| Founder & Chairman of the Scientific Advisory Board | no data | SEK 150.00k | 0.17% SEK 22.0k | |
| Chief Financial Officer | 7.2yrs | pas de données | 0.33% SEK 42.1k | |
| Chief Technology Officer | 9.5yrs | SEK 120.74k | 0.012% SEK 1.5k | |
| Chief Medical Officer | 1.5yrs | pas de données | pas de données | |
| Chief Regulatory Officer | 1.3yrs | pas de données | pas de données |
1.5yrs
Durée moyenne de l'emploi
62yo
Âge moyen
Gestion expérimentée: IDOGEN's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Acting CEO & Director | 6.2yrs | SEK 454.00k | 0.060% SEK 7.6k | |
| Founder & Chairman of the Scientific Advisory Board | 7.8yrs | SEK 150.00k | 0.17% SEK 22.0k | |
| Independent Chairman of the Board | 7.3yrs | SEK 407.00k | 0.15% SEK 18.9k | |
| Member of Scientific Advisory Board | 7.8yrs | pas de données | pas de données | |
| Member of Scientific Advisory Board | 2.3yrs | pas de données | pas de données | |
| Independent Director | 3.2yrs | SEK 150.00k | 0.089% SEK 11.1k | |
| Member of Scientific Advisory Board | 2.3yrs | pas de données | pas de données | |
| Member of Scientific Advisory Board | 2.3yrs | pas de données | pas de données | |
| Member of Scientific Advisory Board | less than a year | pas de données | pas de données | |
| Member of Scientific Advisory Board | less than a year | pas de données | pas de données |
2.7yrs
Durée moyenne de l'emploi
64.5yo
Âge moyen
Conseil d'administration expérimenté: IDOGEN's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.